生物医学科学和法律双学位可为您提供知识，成为生物医学研究，开发和商业化多学科团队的一部分。在该学位课程中，您将完成核心生物医学科学单元，以发展基础生物医学科学学科的知识和技能。全面的法律基础研究将帮助您发展成为成功的学习者和法律专业人士所必需的能力。您不仅将获得法律知识，还将获得研究，沟通和争议解决等技能。该学位使您可以灵活地选择生物医学领域的一个主要研究领域或两个次要研究领域。这些可能包括解剖学，人类生物化学，人类生理学，感染和免疫力或细胞和分子生物技术。在法律部分，您将完成入门，一般和高级选修课，其中
A double degree in biomedical science and laws provides you with knowledge to work as part of a multidisciplinary team in biomedical research, development and commercialisation. During this degree, you will complete core biomedical science units that develop knowledge and skills in foundational biomedical science disciplines. Comprehensive core studies in law will assist you in developing the capabilities necessary to be a successful learner and legal professional. You will not only gain knowledge of the law but also skills such as research, communication and dispute resolution. This degree offers you the flexibility to choose one major study area or two minor study areas in biomedical science. These may include anatomical sciences, human biochemistry, human physiology, infection and immunity, or cell and molecular biotechnology. In the law component, you will complete introductory, general and advanced electives that may include internet law, succession law, taxation law or health law. You will also complete four elective units which can include law units or can be from another minor in the university, such as a language.<br><br>You will be taught by professionals with experience across disciplines and established partnerships with industry that is directly linked to research development and commercialisation. There are opportunities for hands-on learning that will develop your legal skills such as interviewing, negotiation, drafting and advocacy. Students may also choose to complete work experience in am industry, clinical or research-oriented workplace. Biomedical science is a rapidly evolving area, with many exciting career opportunities. Biomedical research and the development of new biomedical products contribute to improving health outcomes worldwide. Governments and organisations, pharmaceutical companies and investment banks continue to invest heavily in this global industry.